All Activity

Finding out that groups like Women Grow and Tokativity are actively using social media and meetups to change perceptions in the cannabis industry-it’s inspiring! Imagine reading this while waiting for my morning coffee, it’s a boost of motivation! @Banana AI

115. 5-MeO-DMT Experience Explained A grounded conversation on the 5-MeO-DMT experience—how it affects the nervous system, how it differs from DMT, and why safety and integration matter. Episode Summary What is 5-MeO-DMT, and why do people describe it so differently from other psychedelics? In this episode, April Pride sits down with licensed clinicians and facilitators Roger and Dustin to explore the 5-MeO-DMT experience through both lived experience and emerging neuroscience. Often referred to as the God molecule psychedelic, 5-MeO-DMT is widely described as a non-visual psychedelic experience—one that quiets the nervous system rather than amplifying imagery, stories, or symbols. Together, they break down 5-MeO-DMT vs DMT, explain how this compound interacts with serotonin receptors in the brain, and discuss why many people report profound ego dissolution, nervous system regulation, and long-term shifts in how they experience safety and connection. This episode also centers women and psychedelics, examining why women—particularly those who have spent years in control, caretaking, or emotional labor—may feel especially drawn to this form of surrender-based medicine. If you’re seeking grounded insight into psychedelic harm reduction, integration after 5-MeO-DMT, and what makes this medicine fundamentally different from other psychedelic experiences, this conversation is an essential listen. Key Takeaways The 5-MeO-DMT experience is often felt rather than seen, with little to no visuals or narrative content Unlike classic psychedelics, 5-MeO-DMT is widely described as a non-visual psychedelic experience Understanding 5-MeO-DMT vs DMT is critical—many vape pens labeled “DMT” contain N-N-DMT, not 5-MeO-DMT 5-MeO-DMT strongly activates both 5-HT2A and 5-HT1A serotonin receptors, impacting cognition and nervous system regulation The medicine often quiets the nervous system rather than stimulating imagery or meaning-making Synthetic 5-MeO-DMT allows for more precise dosing and supports harm reduction by protecting the Sonoran Desert toad Women may experience particular resonance due to lifelong patterns of regulation, control, and emotional labor Psychedelic integration after 5-MeO-DMT is essential; the effects unfold over time, not just during the session Screening, contraindications, and aftercare are non-negotiable components of responsible psychedelic use Timestamps [00:00] What people mean when they describe the God molecule psychedelic [02:10] How Roger and Dustin came to work with 5-MeO-DMT [03:36] Why this is a non-visual psychedelic experience [04:22] Synthetic vs toad-derived 5-MeO-DMT and harm reduction [06:57] Why some therapeutic “stuckness” responds differently to 5-MeO-DMT [08:28] Serotonin receptors and psychedelics: the double-door explanation [10:00] Nervous system regulation and surrender, especially for women [11:14] Gamma brainwaves, endogenous release, and embodied remembering [13:41] April’s experience with DMT vapes and common confusion [16:19] Clear distinctions between 5-MeO-DMT vs DMT [18:30] Health risks, medications, and serotonin syndrome [20:30] Ketamine, DMT, and the limits of comparison [22:53] Why women and psychedelics intersect uniquely here [23:21] Integration, meaning-making, and what comes after the experience Guests Roger & DustinLicensed clinicians and facilitators at Sky Mountain Retreats, specializing in carefully screened, harm-reduction-focused 5-MeO-DMT experiences with an emphasis on preparation, precision dosing, and long-term integration. Additional Resources SetSet Psychedelic Cards Women in the Wild application Learn more about this episode: https://aprilpride.substack.com/p/5-meo-dmt-experience-nervous-system-safety Hosted by April Pride Subscribe for April’s newsletter on Substack at https://aprilpride.substack.com/subscribe or at getsetset.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow on IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@getsetset⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@getsetset⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ / X: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@getsetset Get full access to SetSet with April Pride at aprilpride.substack.com/subscribeCatch the full episode here

Another holiday season has arrived—and, with it, another round of public service announcements from regulators in states that have legalized marijuana that are aimed at advising people about how to comply with the law and stay safe amid the merriment. This has become something of a trend over recent years, with states increasingly using the annual occasion to promote messaging focused on education over stigma to help cannabis consumers better understand the laws—particularly around impaired driving—while also offering advice to prevent overindulgence. This year, cannabis regulators in New Jersey and Virginia have put out holiday-themed social media and blog posts about safe consumption practices. “The holidays are a time for food, fun, laughter, and connecting with the people who make life sweeter,” the New Jersey Cannabis Regulatory Commission (NJ-CRC) said. “And as more adults in New Jersey choose to enjoy, or gift legal cannabis during the season, the NJ-CRC has launched its second safe-use campaign, S.M.A.R.T., to help keep celebrations (relatively) stress-free.” The acronym stands for “Safe, Mindful, Aware, Responsible and Thoughtful.” “S.M.A.R.T. is an easy way to remember the basics of responsible cannabis use, especially when travel is constant, roads are chaotic, homes are busy, and curious little ones are wandering,” the officials said. “Whether you’re a host, a guest, a first-time weed shopper, someone who already knows their way around a dispensary, or can roll up with one hand, being S.M.A.R.T. helps everyone to relax and enjoy the season,” the state blog post says. “Be Safe. Be Mindful. Be Aware. Be Responsible. Be Thoughtful. Be S.M.A.R.T. this holiday season.” Wishing you a holiday season filled with love, happiness, and good vibes. If cannabis is a part of your celebration, keep it away from kids, use in moderation, and don’t drive high. pic.twitter.com/iTRWhB3nAG — New Jersey Cannabis Regulatory Commission (@NewJerseyCRC) December 22, 2025 On X, NJ-CRC emphasized that people who use marijuana in compliance with state law should not drive after using cannabis, ensure that marijuana products are kept away from children and practice moderation. Virginia’s Cannabis Control Authority (CCA), meanwhile, shared a post stressing the importance of understanding the state’s unique marijuana law, particularly as it concerns “gifting.” Planning to give the gift of green this year? (wink*wink*) Before you do, make sure you’re doing it legally. We break down legal adult exchanges of cannabis: https://t.co/ELOe9YUjNV pic.twitter.com/VCGNmDF91f — Virginia Cannabis Control Authority (@Virginia_CCA) December 4, 2025 Possession, as well as non-commercial gifting, of cannabis is permitted under the current law in Virginia. But there are certain policy parameters to keep in mind as lawmakers look to 2026 to establish a retail market under an incoming pro-reform governor. “While ‘adult sharing’ of cannabis between people 21 years and older is legal in Virginia, this term only applies to specific situations. Other exchanges may be illegal and can carry penalties. Common illegal exchanges are known as ‘gifting schemes,'” the CCA’s guidance says. “‘Gifting’ cannabis to someone as part of the sale of another good or service, like a sticker or seminar” is not legal, it says. Several other states—from California to New York—have also historically publicized public education campaigns around the holidays in recent years. About one in three Americans say their holiday “pregame” routine involves using marijuana, according to a new survey. Mainstream media outlets this past November also picked up on a trend that’s long been practiced within the cannabis community: the “cousin walk,” a Thanksgiving pre-game (and usually pre-dinner) tradition for some where the typically younger adults at a gathering will sneak away for a cannabis break before the feast begins. The post State Marijuana Regulators Share Tips On How To Stay Safe And Legal Around The Holidays appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Attorneys general for 19 states and Washington, D.C. are siding with the federal government in a U.S. Supreme Court case that could decide the fate of a law preventing marijuana users from buying or possessing firearms. In an amicus brief for the case U.S. v. Hemani that was submitted to the court on Friday, the top state prosecutors—led by Illinois Attorney General Kwame Raoul (D)—said justices should maintain the current statute known as 18 U.S.C. § 922(g)(3). That law has been challenged in multiple federal courts in recent years, but the Supreme Court agreed to take up Hemani, a case that led a lower court to rule that the federal prohibition on gun ownership by people who use cannabis violates the Second Amendment of the U.S. Constitution. “I am urging the Supreme Court to reverse the appellate court’s decision because the mix of habitual drug use and firearms poses recognized public safety risks,” Raoul said in a press release. “Allowing habitual drug users to carry or use firearms significantly increases danger to our communities.” “I am proud to lead this bipartisan coalition, as we all agreed we need to work together to protect our states and communities from gun violence,” he said. In the brief, the attorneys general—most of which represent states that have enacted adult-use legalization within their borders—said they have a “substantial interest in the health, safety, and welfare of their communities, which includes preventing firearms from coming into the hands of people likely to misuse them.” “That interest is implicated by this case, which addresses the extent to which the federal government may prohibit an individual who is an ‘unlawful user of or addicted to any controlled substance’ from possessing firearms,” they said. The brief doesn’t focus singularly on the marijuana and gun issue, which can be partly explained by the fact that the defendant in the case was not only a cannabis consumer but also a user of cocaine who’s sold drugs in the past, according to court findings. But the impact of a ruling would likely have substantial implications for marijuana consumers and patients. The reasoning that other courts have used to deem the firearm ban unconstitutional is “flawed in multiple respects,” the attorneys general said, “including that it misdescribes the scope of the relevant historical tradition, misapplies this Court’s precedents, and unduly ties the hands of legislatures seeking to protect the public from the full range of dangers associated with combining firearms and drugs.” While the district court in Hemani argued that gun statutes should distinguish between people who are actively impaired from controlled substances and drug users who don’t possess guns while intoxicated, the latter group, the brief says that “habitual drug use can cause some individuals to experience chronic psychological disturbances that affect their conduct and decision-making in a manner that compromises their ability to safely handle firearms.” “Further, because much drug use is illicit, habitual drug users frequently interact with the illegal drug trade, which is inherently dangerous,” it says. The brief cites a related case, U.S. v. Harris, where a regular cannabis user lost his gun after becoming intoxicated and the weapon ended up in the hands of a felon who was prohibited from possessing firearms. “In short, amici States have a substantial interest in retaining the flexibility to address new societal concerns with appropriately tailored firearms regulations that are consistent with the principles underlying this country’s historical tradition. Section 922(g)(3), as well as its state counterparts, respect that balance.” Crime trends across the country show that the “altered mental states caused by these and other drugs can be dangerous when combined with firearms, even when an individual user does not necessarily intend violence or harm or even fire the weapon,” the state officials said. Other signatories of the amicus brief include the attorneys general of California, Colorado, Connecticut, Delaware, Hawaii, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New York, Ohio, Oregon, Rhode Island, Vermont, Washington State and Washington, D.C. Notably, all of those states have legalized adult-use marijuana, with the exception of Hawaii, where only medical cannabis is legal. “Drugs and guns are a dangerous combination,” California Attorney General Rob Bonta (D) said. “Potentially dangerous drug users should not possess firearms—this is a commonsense notion to prevent people who use drugs from harming themselves, their loved ones, or their communities.” “Both red and blue states alike—recognizing the dangers posed by combining habitual drug use with firearms—have imposed firearm restrictions to prevent gun violence,” he said, adding that justices should “reverse a lower court decision, uphold public safety, and keep firearms out of the reach of people who are drug users.” Several other briefs were also submitted on Friday to justices in the case, which was granted cert last month. Firearm control groups including Everytown for Gun Safety, Second Amendment Law Scholars, Brady Center to Prevent Gun Violence, Giffords Law Center to Prevent Gun Violence and Global Action on Gun Violence have told the Supreme Court to overturn the lower court’s ruling in the matter, for example. A coalition of history and law professors also submitted a brief. Also last week, Smart Approaches to Marijuana (SAM) and 21 other prohibitionist groups filed a brief, urging justices to uphold the constitutionality of the federal gun ban for people who use cannabis—which they claim is associated with violence and psychosis. U.S. Solicitor General D. John Sauer, for his part, told the Supreme Court that people who use illegal drugs “pose a greater danger” than those who drink alcohol. The latests amicus briefs were filed just one day after President Donald Trump signed an executive order directing U.S. Attorney General Pam Bondi to expeditiously complete a rulemaking process to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). It’s uncertain to what extent, if at all, the modest policy change would impact the pending gun cases. Meanwhile, the Biden administration was evidently concerned about potential legal liability in federal cases for people convicted of violating gun laws simply by being a cannabis consumer who possessed a firearm, documents recently obtained by Marijuana Moment show. The previously unpublished 2024 guidance from former President Joe Biden’s Justice Department generally cautioned U.S. attorneys to use discretion in prosecuting federal cannabis cases, particularly for offenses that qualified people for pardons during his term. But one section seems especially relevant as the Supreme Court takes on a case challenging the constitutionality of the current federal gun statute. With respect to Hemani, in a separate August filing for the case, the Justice Department also emphasized that “the question presented is the subject of a multi-sided and growing circuit conflict.” In seeking the court’s grant of cert, the solicitor general also noted that the defendant is a joint American and Pakistani citizen with alleged ties to Iranian entities hostile to the U.S., putting him the FBI’s radar. Now that the Supreme Court has agreed to take up Hemani, if justices declare 922(g)(3) constitutional, such a ruling could could mean government wins in the remaining cases. The high court last month denied a petition for cert in U.S. v. Cooper, while leaving pending decisions on U.S. v. Daniels and U.S. v. Sam. The court also recently denied a petition for cert in another gun and marijuana case, U.S. v. Baxter, but that wasn’t especially surprising as both DOJ and the defendants advised against further pursing the matter after a lower court reinstated his conviction for being an unlawful user of a controlled substance in possession of a firearm. Meanwhile, in recent interviews with Marijuana Moment, several Republican senators shared their views on the federal ban on gun possession by people who use marijuana—with one saying that if alcohol drinkers can lawfully buy and use firearms, the same standard should apply to cannabis consumers. Separately, the U.S. Court of Appeals for the Tenth Circuit earlier this year sided with a federal district court that dismissed an indictment against Jared Michael Harrison, who was charged in Oklahoma in 2022 after police discovered cannabis and a handgun in his vehicle during a traffic stop. The case has now been remanded to that lower court, which determined that the current statute banning “unlawful” users of marijuana from possessing firearms violates the Second Amendment of the Constitution. The lower court largely based his initial decision on an interpretation of a Supreme Court ruling in which the justices generally created a higher standard for policies that seek to impose restrictions on gun rights. In the U.S. Court of Appeals for the Eleventh District, judges recently ruled in favor of medical cannabis patients who want to exercise their Second Amendment rights to possess firearms. As a recent report from the Congressional Research Service (CRS) explained the current legal landscape, a growing number of federal courts are now “finding constitutional problems in the application of at least some parts” of the firearms prohibition. In a recent ruling, a three-judge panel for the U.S. Court of Appeals for the Eighth Circuit vacated a defendant’s conviction and remanded the case back to a district court, noting that a retrial before a jury may be necessary to determine whether cannabis in fact caused the defendant to be dangerous or pose a credible threat to others. The Third Circuit separately said in a published opinion that district courts must make “individualized judgments” to determine whether 922(g)(3) is constitutional as applied to particular defendants. A federal court in October agreed to delay proceedings in a years-long Florida-based case challenging the constitutionality of the ban on gun ownership by people who use medical marijuana, with the Justice Department arguing that the Supreme Court’s recent decision to take up Hemani warrants a stay in the lower court. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Earlier this year, a federal judge in Rhode Island ruled that the ban was unconstitutional as applied to two defendants, writing that the government failed to establish that the “sweeping” prohibition against gun ownership by marijuana users was grounded in historical precedent. A federal judge in El Paso separately ruled late last year that the government’s ongoing ban on gun ownership by habitual marijuana users is unconstitutional in the case of a defendant who earlier pleaded guilty to the criminal charge. The court allowed the man to withdraw the plea and ordered that the indictment against him be dismissed. DOJ has claimed in multiple federal cases over the past several years that the statute banning cannabis consumers from owning or possessing guns is constitutional because it’s consistent with the nation’s history of disarming “dangerous” individuals. In 2023, for example, the Justice Department told the U.S. Court of Appeals for the Third Circuit that historical precedent “comfortably” supports the restriction. Cannabis consumers with guns pose a unique danger to society, the Biden administration claimed, in part because they’re “unlikely” to store their weapon properly. Meanwhile, some states have passed their own laws either further restricting or attempting to preserve gun rights as they relate to marijuana. Recently a Pennsylvania lawmaker introduced a bill meant to remove state barriers to medical marijuana patients carrying firearms. Colorado activists also attempted to qualify an initiative for November’s ballot that would have protected the Second Amendment rights of marijuana consumers in that state, but the campaign’s signature-gathering drive ultimately fell short. As 2024 drew to a close, the ATF issued a warning to Kentucky residents that, if they choose to participate in the state’s medical marijuana program that’s set to launch imminently, they will be prohibited from buying or possessing firearms under federal law. The official said that while people who already own firearms aren’t “expected to” turn them over if they become state-legal cannabis patients, those who “wish to follow federal law and not be in violation of it” must “make the decision to divest themselves of those firearms.” Since then, bipartisan state lawmakers have introduced legislation that would urge Kentucky’s representatives in Congress to amend federal law to clarify that users of medical marijuana may legally possess firearms, though no action has since been taken on that bill. Kentucky Gov. Andy Beshear (D) said in January that he supported the legislature’s effort to urge the state’s congressional delegation to call for federal reforms to protect the Second Amendment rights of medical marijuana patients, but the governor added that he’d like to see even more sweeping change on the federal level. The post Supreme Court Should Uphold Gun Ban For Marijuana Users, 19 State AGs Tell Justices appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The head of the major gardening supply company Scotts Miracle-Gro says President Donald Trump called a proposal to move marijuana from Schedule I to Schedule II—rather than Schedule III, as he ultimately directed last week—a “half-assed” move amid “hardcore arguing” in discussions about the reform. Scotts Miracle-Gro CEO Jim Hagedorn—whose Hawthorne Gardening Company unit provides supplies for cannabis growers—told NewsNation that a two hour and 15 minute meeting in the Oval Office about rescheduling this month was “insane,” with heated debate over the policy change “led by the president.” “I could see that the president was sympathetic, but I could also see there was tension in the air. He led the meeting,” he said. “The president rightfully said, ‘We’re not doing [Schedule II]—II is a half-assed version of III. We’re doing III or we do nothing.'” Hagedorn—who said back in August that Trump had told him directly “multiple times” that he intended to see through the marijuana rescheduling process—took some credit for the president’s decision to sign an executive order directing the attorney general to complete the marijuana rescheduling process. He said that, “if it hadn’t been our willingness to stand behind it and see it through,” the Hawthorne Gardening Company would have “gone out of business.” He added that multiple cannabis companies have gone under as the reform sat in flux. The CEO was among many stakeholders to weigh in on the president’s order on rescheduling, which would not federally legalize marijuana but would send a symbolic message while loosening certain research restrictions and allow cannabis businesses to take federal tax deductions under an Internal Revenue Service (IRS) code known as 280E. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” he said. “President Trump deserves credit and praise for taking this bold action, as it reflects the will of the people and sets the stage for much-needed research into the medical use of cannabis.” Scotts Miracle-Gro, meanwhile, has also lobbied at the federal level on cannabis issues such as marijuana industry banking access. Trump’s decision to advance rescheduling came at the behest of other cannabis and cannabis-adjacent entrepreneurs as well, including the CEO of the multi-marijuana business Trulieve. Meanwhile, a GOP senator suggested last week that that Trump lied when he said during the signing ceremony for a marijuana rescheduling executive order that he hadn’t received any calls in opposition to the reform. During last week’s event, Trump noted strong public support for marijuana reform and said numerous people called him to voice support for cannabis rescheduling. Photo courtesy of Mike Latimer. The post Trump Rejected ‘Half-Assed’ Plan To Move Marijuana To Schedule II During ‘Insane’ Oval Office Meeting, ScottsMiracle-Grow CEO Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Teen marijuana use “remained stable” this year even as more states have enacted legalization, according to an annual federally funded survey The Monitoring the Future (MTF) survey—supported by the National Institute on Drug Abuse (NIDA) and conducted every year for decades by the University of Michigan—examines substance use trends among 8th, 10th and 12th grade students. And the latest results add to a large body of evidence contradicting prohibitionist claims that state-level legalization would drive increases in underage cannabis usage. The rate of past-year marijuana use for 12th graders was 25.7 percent, which is relatively consistent with recent years but at its lowest level since 1992. It was the same case with 10th graders, 15.6 percent of whom used marijuana in the last year. Among 8th grade students, 7.6 percent reported past-year cannabis consumption. For past-month cannabis use, that rate was 17.1 percent for 12th graders, a slight uptick from the prior year but significantly lower than its record high of 37.1 percent in 1978 before any state had legalized cannabis for adult or medical use. For 10th grade students, the rate this past year was 9.4 percent, and for 8th grade it was 4 percent—consistent with recent years. “We are encouraged that adolescent drug use remains relatively low and that so many teens choose not to use drugs at all,” NIDA Director Nora Volkow said in a press release. “It is critical to continue to monitor these trends closely to understand how we can continue to support teens in making healthy choices and target interventions where and when they are needed.” The survey also found that students who reported past-month abstention from marijuana , alcohol and nicotine were “stable for all grades” (66 percent for 12th grade, 82 percent for 10th grade and 91 percent for 8th grade). The survey also asked about the use of hemp-based cannabinoid products, including intoxicating compounds such as delta-8 THC. It found that 9 percent of 12th graders, 6 percent of 10th graders and 2 percent of 8th graders used products in that category in the past year. This year’s MTF survey was based on data from 23,726 student surveys submitted from 270 public and private schools from February-June 2025. To reform advocates, the results of the survey reinforce the idea that creating a regulatory framework for cannabis where licensed retailers must check IDs and implement other security mechanisms to prevent unlawful diversion is a far more effective policy than prohibition, with illicit suppliers whose products may be untested and where age-gating isn’t a strictly enforced regulation. To that point, a separate federally funded study out of Canada that was released last month found that that youth marijuana use rates actually declined after the country legalized cannabis. The study was released about three months after German officials released a separate report on their country’s experience with legalizing marijuana nationwide. Back in July, federal health data also indicated that while past-year marijuana use in the U.S. overall has climbed in recent years, the rise has been “driven by increases…among adults 26 years or older.” As for younger Americans, rates of both past-year use and cannabis use disorder, by contrast, “remained stable among adolescents and young adults between 2021 and 2024.” Across the U.S., research suggests that marijuana use by young people has generally fallen in states that legalize the drug for adults. A report from the advocacy group Marijuana Policy Project (MPP), for example, found that youth marijuana use declined in 19 out of 21 states that legalized adult-use marijuana—with teen cannabis consumption down an average of 35 percent in the earliest states to legalize. The report cited data from a series of national and state-level youth surveys, including the annual MTF survey. Another survey from the U.S. Centers for Disease Control and Prevention (CDC) last year also showed a decline in the proportion of high-school students reporting past-month marijuana use over the past decade, as dozens of states moved to legalize cannabis. At the state level, MPP’s assessment looked at research such as the Washington State Healthy Youth Survey that was released in April 2024. That survey showed declines in both lifetime and past-30-day marijuana use in recent years, with striking drops that held steady through 2023. The results also indicated that perceived ease of access to cannabis among underage students has generally fallen since the state enacted legalization for adults in 2012—contrary to fears repeatedly expressed by opponents of the policy change. In June of last year, meanwhile, the biannual Healthy Kids Colorado Survey found that rates of youth marijuana use in the state declined slightly in 2023—remaining significantly lower than before the state became one of the first in the U.S. to legalize cannabis for adults in 2012. The findings broadly track with other past surveys that have investigated the relationship between jurisdictions that have legalized marijuana and youth cannabis use. For example, a Canadian government report recently found that daily or near-daily use rates by both adults and youth have held steady over the last six years after the country enacted legalization. Another U.S. study reported a “significant decrease” in youth marijuana use from 2011 to 2021—a period in which more than a dozen states legalized marijuana for adults—detailing lower rates of both lifetime and past-month use by high-school students nationwide. Another federal report published last summer concluded that cannabis consumption among minors—defined as people 12 to 20 years of age—fell slightly between 2022 and 2023. Separately, a research letter published by the Journal of the American Medical Association (JAMA) in April 2024 said there’s no evidence that states’ adoption of laws to legalize and regulate marijuana for adults have led to an increase in youth use of cannabis. Another JAMA-published study earlier that month that similarly found that neither legalization nor the opening of retail stores led to increases in youth cannabis use. In 2023, meanwhile, a U.S. health official said that teen marijuana use has not increased “even as state legalization has proliferated across the country.” Another earlier analysis from the U.S. Centers for Disease Control and Prevention found that rates of current and lifetime cannabis use among high school students have continued to drop amid the legalization movement. A separate NIDA-funded study published in the American Journal of Preventive Medicine in 2022 also found that state-level cannabis legalization was not associated with increased youth use. The study demonstrated that “youth who spent more of their adolescence under legalization were no more or less likely to have used cannabis at age 15 years than adolescents who spent little or no time under legalization.” Yet another 2022 study from Michigan State University researchers, published in the journal PLOS One, found that “cannabis retail sales might be followed by the increased occurrence of cannabis onsets for older adults” in legal states, “but not for underage persons who cannot buy cannabis products in a retail outlet.” The trends were observed despite adult use of marijuana and certain psychedelics reaching “historic highs” in 2022, according to separate 2023 data. The post Teen Marijuana Use ‘Remained Stable’ As Legalization Expands, Federal Health Officials Acknowledge appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The net will be bogged straight down together with fake sites without genuine concept nevertheless the submit has been great and also worth the particular examine. Many thanks regarding revealing this kind of with me at night. free 1xbet promo code today

A Democratic senator has filed a bill aimed at laying the groundwork for federal marijuana legalization. Sen. John Hickenlooper (D-CO) introduced the legislation—titled the Preparing Regulators Effectively for a Post-Prohibition Adult-Use Regulated Environment Act (PREPARE) Act—on Thursday. The measure would direct the attorney general to create a commission charged with making recommendations on a regulatory system for cannabis that models what’s currently in place for alcohol. It was filed on the same day that President Donald Trump issued an executive order directing marijuana to be rescheduled from Schedule I to Schedule III of the Controlled Substances Act. Reps. Dave Joyce (R-OH) and House Minority Leader Hakeem Jeffries (D-NY) introduced a version of the cannabis commission bill in the House in April, and Hickenlooper has sponsored iterations of the legislation over the past two Congresses. Hickenlooper, who served as governor of Colorado when voters approved a recreational cannabis legalization initiative in 2012, which he campaigned against at the time, said in a social media post on Monday that Trump’s marijuana executive order represents “another example of Colorado blazing the trail.” “Now release and expunge records for everyone who was charged with federal marijuana crimes,” he said, “and let’s pass our bill to prepare us for federal legalization while we’re at it.” Another example of Colorado blazing the trail. Now release and expunge records for everyone who was charged with federal marijuana crimes – and let's pass our bill to prepare us for federal legalization while we're at it. pic.twitter.com/b6P9wl4H1H — Senator John Hickenlooper (@SenatorHick) December 22, 2025 Here’s what the bill would accomplish: Require the attorney general to establish a “Commission on the Federal Regulation of Cannabis” within 30 days of the bill’s enactment. The commission would be responsible for studying federal and state regulatory models for alcohol and make recommendations about how they could inform marijuana regulations. Among other things, the commission’s report must look at the impact of marijuana criminalization, particularly as it concerns minority, low-income and veteran communities. The panel would also examine the “lack of consistent regulations for cannabis product safety, use and labeling requirements,” including those related to youth safety, as well as the “lack of guidance for cannabis crop production, sale, intrastate, interstate, and international trade.“ It would also need to make recommendations on how to remedy cannabis-related banking and research barriers as well as address measures to ensure the “successful coexistence of individual hemp and cannabis industries, including prevention of cross pollination of cannabis and hemp products.” Members would further be mandated to study and make recommendations on “efficient cannabis revenue reporting and collecting, including efficient and tenable federal revenue frameworks.” The panel would be required to issue a report to Congress within 12 months. The commission would also include representatives of: Department of Health and Human Services Department of Justice Department of Agriculture Department of Veterans Affairs Department of Interior Department of Education Department of Labor Department of Treasury Department of Commerce Department of Housing and Urban Development White House Office of National Drug Control Policy National Institutes of Health Alcohol and Tobacco Tax and Trade Bureau Food and Drug Administration Internal Revenue Service Bureau of Alcohol, Tobacco, Firearms and Explosives National Highway Traffic Safety Administration Occupational Safety and Health Administration National Institute of Standards and Technology Small Business Administration U.S. Trade Representative Office of Minority Health Indian Health Service — Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — It would also include a person formerly incarcerated for a non-violent cannabis use or possession crime, a substance use disorder prevention expert, an expert on the history of marijuana criminalization, a person with knowledge about cannabis research, a representative from a trade organization or nonprofit representing highly regulated adult goods and consumer package goods and two people who have worked to develop state-level regulatory systems. Some of the appointments would be made by the attorney general, and others would come from congressional leaders. The bill also contains a stipulation that, “if after the commission is appointed there is a partisan imbalance of commission members, the congressional leaders of the political party with fewer members on the commission shall jointly name additional members to create partisan parity on the commission.” Read the full text of the new marijuana commission bill below: The post Trump’s Attorney General Would Form A Marijuana Commission To Prepare For Federal Legalization Under New Senate Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

To provide a First-time, My group is eternally visiting web based designed for articles and reviews which is in be an aid to all of us. Thanks for your time. 猛健樂副作用

Lawmakers push for more marijuana reform; MA anti-cannabis ballot signatures; NJ psilocybin vote; Poll: Americans use marijuana for holiday stress Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The U.S. Department of Transportation sent a notice clarifying that President Donald Trump’s marijuana rescheduling executive order “will not change” federal drug testing process and regulations for safety‐sensitive transportation workers—at least “until any rescheduling is complete.” Bipartisan members of Congress say that President Donald Trump’s marijuana rescheduling order is only the first step toward needed reforms—and that cannabis industry banking access, sentencing reform and full legalization should follow. The Massachusetts Secretary of the Commonwealth’s Elections Division certified that a campaign to scale back the marijuana legalization law by recriminalizing recreational sales and home grow got enough signatures to advance its initiative toward the 2026 ballot. The New Jersey Assembly Appropriations Committee approved a bill to legalize psilocybin therapy and create a regulated program for patient access. A new poll shows that nearly one in three Americans “pre-game” with marijuana before family holiday gatherings to emotionally prepare and deal with stress. / FEDERAL A Department of Veterans Affairs spokesperson said marijuana rescheduling won’t allow the agency’s doctors to prescribe medical cannabis but will make it easier to conduct research on marijuana. Former Deputy Assistant Secretary of Defense for Counternarcotics and Stabilization Policy James Saenz co-authored an op-ed criticizing the Trump administration’s military strikes on alleged drug boats. Sen. Cynthia Lummis (R-WY) said she disagrees with President Donald Trump on marijuana rescheduling. Sen. Tom Cotton (R-AR) and Rep. Andy Harris (R-MD) praised the recently approved federal recriminalization of hemp THC products. Rep. Pete Sessions (R-TX) said the White House rejected his request for a meeting with President Donald Trump to express his concerns about marijuana rescheduling. Rep. Greg Steube (R-FL) discussed the benefits of rescheduling marijuana. Former Rep. Matt Gaetz (R-FL) said President Donald Trump “delivered” on marijuana rescheduling when “Obama couldn’t get it done” and “Biden couldn’t get it done.” / STATES California’s attorney general touted efforts to eradicate illegal marijuana plants. Separately, regulators announced a recall of marijuana products due to the company operating as a distributor without a distributor license. A Pennsylvania representative said she is “not going to ever support legalization of recreational marijuana.” Arizona regulators filed changes to marijuana rules. Illinois regulators are proposing changes to marijuana dispensary rules. Colorado regulators published a bulletin about burglaries against marijuana businesses. Oklahoma regulators published guidance about requirements for physicians who want to recommend medical cannabis. Michigan regulators signed a cannabis compact with the Pokagon Band of Potawatomi Indians of Michigan and Indiana. Texas officials awarded $50 million to UTHealth Houston and the University of Texas Medical Branch at Galveston to support ibogaine therapy trials. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / SCIENCE & HEALTH A review concluded that “CBD is a valuable antioxidant agent in skin care science.” A study found that “cognitive performance improved two weeks after receiving psilocybin-assisted psychotherapy.” / ADVOCACY, OPINION & ANALYSIS Former Republican National Committee Communications Director Kevin Heye said President Donald Trump’s marijuana rescheduling order sends a “mixed message.” The Heritage Foundation criticized President Donald Trump’s move to reschedule marijuana. Gun Owners of America tweeted, “President Trump just ordered that marijuana be reclassified from Schedule I to Schedule III. GOA is calling on ATF to cease treating Americans who are prescribed marijuana as ‘unlawful users of controlled substances’ & federally prohibited from possessing firearms.” / BUSINESS Atai Beckley N.V. received a U.S. patent for its oral R-MDMA medication. Canadian retailers sold C$451.7 million worth of legal marijuana products in October. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Mike Latimer. The post Will cannabis rescheduling affect drug testing for safety-sensitive workers? (Newsletter: December 23, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. slot1000 Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. koi toto Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. ταρω

In the form of Inexperienced, Now i'm once and for good seeking via the internet just for articles or reviews which has been about help others. With thanks. resorts for sale in the caribbean

This is exactly the text I'm sure uncovering everywhere you look. Thanks a lot for a blog page, I just join up your website. That is the decent blog page. inches. resorts for sale in the caribbean

My spouse and i shocked while using investigation anyone created to choose this certain release outstanding. Amazing task! resorts for sale in the caribbean

This can be a excellent ideas particularly in order to individuals a new comer to blogosphere, short as well as precise information… Many thanks with regard to discussing that one. Essential study post. resorts for sale in the caribbean

Awesome posting, it has the such a interesting site there is listed here, keep up to date favorable deliver the results, might be backside. resorts for sale in the caribbean

About one in three Americans say their holiday “pregame” routine involves using marijuana, according to a new survey. The poll from the Freeman Recovery Center looked at a variety of ways the use of alcohol and other drugs intersects with with the holiday season, when family get-togethers and financial stress from gift giving tend to come to a head. As it turns out, a sizable portion of Americans are using cannabis to decompress. “Because holiday celebrations are so ingrained in American culture, it can be challenging to pinpoint what exactly exacerbates substance use behaviors around this time of year. However, we wanted to figure out why,” the center said. The survey of over 1,000 respondents “revealed that for many, substances like alcohol weren’t just part of holiday parties, but a way to endure the season,” it said. About half of Americans said they “pre-game” before holiday family gatherings. Alcohol is the most common choice at 51 percent, but cannabis now comes in second at 31 percent—including 43 percent of Gen Z and millennials. Another 12 percent said they used psychedelics before family events. For people with a substance use history, that increased: 68 percent used alcohol, 50 percent consumed cannabis and 26 percent opted for psychedelics. “Despite financial stress being a common experience during the holidays, not every generation turned to substances. For example, 42 percent of Gen X and 68 percent of baby boomers said they had not used substances to cope with holiday financial pressure,” the center said. “On the other hand, millennials reported the most self-medication when faced with financial stress, with 54 percent using alcohol and 45 percent using cannabis.” The data on cannabis usage during the holidays isn’t especially surprising, as more than half of American adults report having use cannabis, according to a 2023 Pew poll from this summer, and 23 percent said they consumed marijuana in the prior year. When it comes to holidays specifically, mainstream media outlets this past November picked up on a trend that’s long been practiced within the cannabis community: the “cousin walk,” a Thanksgiving pre-game (and usually pre-dinner) tradition for some where the typically younger adults at a gathering will sneak away for a cannabis break before the feast begins. Photo courtesy of Martin Alonso. The post One In Three Americans ‘Pre-Game’ With Marijuana Before Family Holiday Gatherings, Survey Finds appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The U.S. Department of Transportation (DOT) is advising that all safety-sensitive workers must still comply with federal drug testing requirements, even as the president directs the attorney general to complete a cannabis rescheduling process. However, the department didn’t quite specify what would change if marijuana is ultimately moved from Schedule I to Schedule III of the Controlled Substances Act (CSA) After President Donald Trump signed an executive order on cannabis rescheduling last week, DOT issued a notice saying it’s received “inquiries” about the impact of the potential reform on the department’s “longstanding regulation about the use of marijuana by safety‐sensitive transportation employees.” That includes “pilots, school bus drivers, truck drivers, train engineers, subway operators, aircraft maintenance personnel, transit fire‐armed security personnel, ship captains, and pipeline emergency response personnel, among others.” DOT clarified that, until Attorney General Pam Bondi finalizes the rescheduling action, marijuana remains a Schedule I drug. Therefore, it “remains unacceptable for any safety‐sensitive employee subject to drug testing under the Department of Transportation’s drug testing regulations to use marijuana.” Additionally, “Until the rescheduling process is complete, the Department of Transportation’s drug testing process and regulations will not change,” the notice says. “Transportation employees in safety-sensitive positions will still be subject to testing for marijuana,” DOT said. “Furthermore, the Department’s guidance on medical and recreational marijuana and CBD are still in effect.” Laboratories, medical review officers and substance misuse professionals must still comply with existing drug testing rules, so there are “no changes to your roles and responsibilities as they relate to marijuana.” “We will continue to monitor the rescheduling process and update the transportation industry as appropriate,” the department said. “We want to assure the traveling public that our transportation system is the safest it can possibly be.” While it seemed as if DOT was leaving room open for a possible internal policy change if marijuana rescheduling is ultimately finalized, former Transportation Secretary Pete Buttigieig said last year that placing cannabis in Schedule III wouldn’t affect drug testing policies for commercial truckers, noting that the department specifically lists marijuana as substance to screen. “Our understanding of the rescheduling of marijuana from Schedule I to schedule III is that it would not alter DOT’s marijuana testing requirements with respect to the regulated community,” the former Biden administration official said. “For private individuals who are performing safety-sensitive functions subject to drug testing, marijuana is identified by name, not by reference to one of those classes. So even if it moves in its classification, we do not believe that that would have a direct impact on that authority.” The reason rescheduling on its own wouldn’t change DOT policy is based on an interpretation of the 1991 Omnibus Transportation Employee Testing Act, which grants the transportation secretary with discretion to test for any controlled substances that they’ve “determined has a risk to transportation safety.” Buttigieg was responding to a question from Rep. Rick Crawford (R-AR) during a House Transportation and Infrastructure Committee hearing. The congressman had referenced concerns from the American Trucking Associations (ATA) “about the broad public health and safety consequences of reclassification on the national highway system and its users.” The latest notice comes about three months after DOT proposed a separate rule to update its drug testing guidelines, revising terminology around cannabis in a way that provides more specificity related to THC. While it’s widely understood that driving under the influence of cannabis is dangerous, the relationship between consumption and impairment is a messy one. Last year, for example, a scientific review of available evidence on the relationship between cannabis and driving found that most research “reported no significant linear correlations between blood THC and measures of driving,” although there was an observed relationship between levels of the cannabinoid and reduced performance in some more complex driving situations. “The consensus is that there is no linear relationship of blood THC to driving,” the paper concluded. “This is surprising given that blood THC is used to detect cannabis-impaired driving.” In a separate report last year, NHTSA said there’s “relatively little research” backing the idea that THC concentration in the blood can be used to determine impairment, again calling into question laws in several states that set “per se” limits for cannabinoid metabolites. “Several states have determined legal per se definitions of cannabis impairment, but relatively little research supports their relationship to crash risk,” that report says. “Unlike the research consensus that establishes a clear correlation between [blood alcohol content] and crash risk, drug concentration in blood does not correlate to driving impairment.” Similarly, a Department of Justice (DOJ) researcher said last February that states may need to “get away from that idea” that marijuana impairment can be tested based on the concentration of THC in a person’s system. “If you have chronic users versus infrequent users, they have very different concentrations correlated to different effects,” Frances Scott, a physical scientist at the National Institute of Justice (NIJ) Office of Investigative and Forensic Sciences under DOJ, said. Photo courtesy of Martin Alonso. The post Trump’s Marijuana Order Doesn’t Change Drug Testing For Safety-Sensitive Workers, At Least For Now, Transportation Department Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

New Jersey lawmakers have approved a bill to legalize therapeutic access to psilocybin for adults with qualifying health conditions. Weeks after the Assembly Health Committee advanced the legislation—sponsored by Assemblymembers Herb Conaway (D), Clinton Calabrese (D) and Anthony Verrelli (D)—the Assembly Appropriations Committee signed off on it on Thursday. The Health panel last year amended the legislation in a way that aligns in with a Senate version. To advocates’ disappointment, however, that meant removing provisions that would have more broadly legalized psilocybin for adult use. Initially, the legislation was introduced in identical form to what lawmakers proposed in the 2024 session—a plan that included personal legalization provisions, which the recent amended versions takes out. Those components would have made it legal for adults to “possess, store, use, ingest, inhale, process, transport, deliver without consideration, or distribute without consideration, four grams or less of psilocybin.” The amended measures would nevertheless significantly expand on legislation introduced in late 2020 to reduce penalties for possession of up to one ounce of psilocybin. That reform that was signed into law by Gov. Phil Murphy (D) in 2021. Assemblywoman Lisa Swain (D), who chairs the Appropriations Committee, described the bill on Thursday as a “first step.” “I mean, you’ve heard the testimony here,” she said, referring to witnesses who argued that broader reform is needed. “This bill creates an advisory board that will be able to make determinations—for instance, whether it should be natural mushrooms or synthetic mushrooms. So that option is still on the table. It’s a pilot program and we want to get started to make sure that, as you heard, people who really need to be treated” can get access. In its amended version, the bill would charge the Department of Health (DOH) with licensing and regulating the manufacture, testing, transport, delivery, sale and purchase of psilocybin. There would be five license types: manufacturer, service center operator, testing laboratory, facilitator and psilocybin worker. A Psilocybin Advisory Board would establish qualifying medical conditions for use, propose guidelines for psilocybin services and dosage, craft safety screenings and informed consent practices and oversee facilitator education, training and conduct. Its stated goal would be to develop a long-term strategic plan for safe, accessible and affordable access to psilocybin for all people 21 and older. Toward that goal, a social equity program would be tasked with establishing financial assistance to help low-income people cover costs of psilocybin services. DOH would also be directed to establish programs for technical assistance, reduced fees and other support services. In order to access the psilocybin services under the bill, a patient with a qualifying condition would need to obtain a referral from a licensed health care professional. Services would also include mandatory preparation and integration sessions before and after the administration of psilocybin. The Senate companion version of the bill has already cleared two panels in that chamber—the Health, Human Services and Senior Citizens Committee and the Budget and Appropriations Committee. A survey of New Jersey residents released last year indicates that a majority of state residents agree with making psilocybin available for therapeutic use, though they weren’t asked specifically about the specific legislation. The poll, from Stockton University’s William J. Hughes Center for Public Policy, found that 55 percent of respondents supported legalizing psilocybin for medical use under a doctor’s supervision. Just 20 percent of respondents were opposed, while 24 percent said they weren’t sure. One percent of respondents refused to answer the question. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In other New Jersey drug policy news, voters last month elected U.S. Rep. Mikie Sherrill (D-NJ) to serve as the state’s next governor, and there’s now a decidedly clearer path to advancing a marijuana reform long awaited by consumers and advocates in the Garden State: A home grow option. Meanwhile, as New Jersey’s first marijuana consumption lounges opened up over the summer, regulators shared information about where to find the sites and offering tips about how to responsibly use cannabis at the licensed businesses—including classic stoner cultural customs like “puff, puff, pass.” New Jersey officials have also completed the curriculum of a no-cost marijuana training academy that’s meant to support entrepreneurs interested in entering the cannabis industry. Separately, in May New Jersey Senate President Nick Scutari (D) filed a bill that would re-criminalize purchasing marijuana from unlicensed sources—one of the latest attempts to crack down on the illicit market and steer adults toward licensed retailers. In March, a former New Jersey Senate leader unsuccessfully ran for the Democratic gubernatorial nomination this year said “it is time” to give medical marijuana patients an option to grow their own cannabis plants for personal use. He also pledged to expand clemency for people impacted by marijuana criminalization if elected, and he expressed support for the establishment of cannabis consumption lounges. The comments from Sweeney, who was the longest-serving Senate president in the state’s history, on home grow depart from what the current governor has said on multiple occasions, arguing that the state’s adult-use marijuana market needs to further mature before home grow is authorized. Seemingly contradicting that claim, dozens of New Jersey small marijuana businesses and advocacy groups recently called on the legislature to allow adults to cultivate their own cannabis. Photo courtesy of Wikimedia/Mushroom Observer. The post New Jersey Bill To Legalize Psilocybin Therapy Clears Another Assembly Committee appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Massachusetts officials have announced that the campaign behind an initiative to roll back the state’s marijuana legalization law collected enough valid signatures to send the measure to lawmakers for consideration before it potentially gets put in front of voters to decide next on year’s ballot. As of Thursday, the Secretary of the Commonwealth’s Elections Division said it certified 78,301 signatures for the petition, titled “An Act to Restore a Sensible Marijuana Policy.” The initiative would still let adults 21 and older possess and gift up to an ounce of cannabis, but it would repeal provisions of the voter-approved legalization law allowing for commercial sales and home cultivation by adults. “I am pleased to inform you that 78,301 certified signatures of the 79,420 received by this office on or before December 3, 2025, have been allowed,” Michelle Tassinari, first deputy secretary of the Elections Division, said in a notice to the Coalition for a Healthy Massachusetts. “Therefore, the initiative petition will be transmitted to the Clerk of the House of Representatives, as required by the Constitution.” The campaign had already expressed confidence that it secured enough signatures to advance. Lawmakers will receive the proposal at the start of the 2026 session on January 7, and they have until May 5 to act on it. If the choose not to enact it legislatively, the campaign would need to go through another round of petitioning and get at least 12,429 certified signatures by July 1 to make the November ballot. There’s been controversy surrounding the prohibitionist coalition’s signature collection tactics, with allegations that petitioners working on behalf of the campaign shared misleading information about what the measure would accomplish—with claims that paid petitioners have used fake cover letters for other ballot measures on issues like affordable housing and same-day voter registration. The state attorney general’s office has confirmed it’s received complaints to that end. And an association of state marijuana businesses last month urged voters to report to local officials if they observe any instances of “fraudulent message” or other deceitful petitioning tactics. The campaign has denied the allegations. Massachusetts Attorney General Andrea Campbell’s (D) office—which cleared the campaign for signature gathering in September–has stressed to voters the importance of reading their summary, which is required to go at the top of the signature form, before signing any petitions. Meanwhile, the head of Massachusetts’s marijuana regulatory agency recently suggested that the measure to effectively recriminalize recreational cannabis sales could imperil tax revenue that’s being used to support substance misuse treatment efforts and other public programs. Whether the cannabis measures make the cut is yet to be seen. Voters approved legalization at the ballot in 2016, with sales launching two years later. And the past decade has seen the market evolve and expand. As of August, Massachusetts officials reported more than $8 billion in adult-use marijuana sales. Last month, the Massachusetts Senate approved a bill that would double the legal marijuana possession limit for adults and revise the regulatory framework for the state’s adult-use cannabis market. Similar legislation also advanced through the House earlier this year. This month, state regulators finalized rules for marijuana social consumption loungues. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Separately, the state Cannabis Control Commission (CCC) recently launched an online platform aimed at helping people find jobs, workplace training and networking opportunities in the state’s legal cannabis industry. State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments. Also in Massachusetts, legislators who were working on a state budget butted heads with CCC officials, who’ve said they can’t make critical technology improvements without more money from the legislature. Massachusetts lawmakers additionally approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics. And two committees have separately held hearings to discuss additional psilocybin-related measures. Read Massachusetts’s officials notice on the marijuana initiative below: Photo courtesy of Philip Steffan. The post Massachusetts Campaign To Scale Back Marijuana Legalization Has Enough Signatures To Advance Toward Ballot, Officials Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! bandar togel Certainly great, remarkable, fact-filled tips these. Ones own content articles Be required to fail, thinking that obviously is true these on top of that. One normally generate an intriguing browse. On earth do you enlighten So i'm shocked?: )#) Compete the great articles and reviews. togel macau I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. toto slot Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. toto slot Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. situs togel online

President Donald Trump’s marijuana rescheduling executive order represents progress, bipartisan lawmakers say. But with that policy change now moving forward, some key House and Senate members are previewing their priorities for future reform—from giving cannabis businesses access to the banking system to legalizing marijuana altogether. The order Trump signed on Thursday directs the attorney general to complete a process to move cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA), which would not make it legal but would let cannabis businesses take federal tax deductions and lift certain research barriers. The action received uniquely bipartisan praise, a rarity in the current political climate. But Democrats, as well as select GOP lawmakers, are making clear that rescheduling marijuana isn’t the end game, with a range of bills on the table to build upon the incremental reform that they want to push through. That includes the Secure and Fair Enforcement Regulation (SAFER) Banking act to protect banks that service state-licensed cannabis businesses and the Cannabis Administration and Opportunity Act (CAOA) to end federal prohibition and address the harms of the drug war. Here’s what lawmakers are saying about the rescheduling action and goals for additional reform: Senate Minority Leader Chuck Schumer (D-NY) “Though a step in the right direction, more must be done to decriminalize cannabis, ease overly restrictive banking regulations that stall industry progress in states where it is legal, and rectify the harms done by the War on Drugs,” Schumer said. “I remain committed to the SAFER Banking Act and the Cannabis Administration and Opportunity Act to accomplish these goals.” House Minority Leader Hakeem Jeffries (D-NY) Jeffries said he’s “supported marijuana reform throughout my entirety in public service, both in the New York State legislature and as a member of Congress—and have worked with the administration in the past to get criminal justice reform over the finish line connected to the First Step Act,” which deals with sentencing policy. “We welcome any opportunity moving forward to continue that work to right size our criminal justice system to move away from the failed war on drugs,” the minority leader said, “which includes a failed war on marijuana and to deal with the mass incarceration epidemic that this country has suffered from that is both unfair and undermines our economic productivity.” Rep. Dave Joyce (R-OH), co-chair of the Congressional Cannabis Caucus “President Trump’s executive order to move cannabis from Schedule I to Schedule III is a meaningful step forward,” and it’s “reflective of the growing body of scientific evidence and medical research,” Joyce said. “For too long, Schedule I status has blocked research, distorted markets, and denied patients, especially veterans and seniors, access to treatments that could improve their quality of life.” “Rescheduling opens the door to responsible regulation, evidence-based medicine, and a safer, more transparent cannabis market. It will help close the gap in information needed to support informed doctor–patient choice,” he said. Rep. Brian Mast (R-FL), co-chair of the Congressional Cannabis Caucus “President Trump can change the stigma around marijuana that fails to reflect its proven benefits, especially for veterans. By rescheduling, he will expand patient access and advance the America First agenda at a pivotal moment,” Mast said. “From its ability to ease chronic pain to its critical help for veterans healing from both visible and invisible wounds, I applaud President Trump’s decision to reschedule marijuana and improve the quality of life for so many.” Thank you @POTUS for making the critical decision to reschedule marijuana and give veterans better access to heal both visible and invisible wounds. This will improve the life for so many and help stop the dependence on opioids. — Rep. Brian Mast (@RepBrianMast) December 18, 2025 Sen. Jeff Merkley (D-OR) Merkley, who has sponsored the SAFER Banking Act in past sessions, said the rescheduling action is a “step in the right direction, allowing medical research and legal cannabis businesses to be appropriately taxed on their net profits.” “But this change from Schedule I to Schedule III still leaves these cannabis businesses in violation of criminal law because the production and use of cannabis for non-medical purposes remain a federal crime,” he said. “As such, these legal businesses are still prevented from accessing the banking system.” “That remains a huge problem, encouraging all sorts of criminal activities, including robberies of cannabis businesses operating in all cash, false accounting, money laundering, and organized crime. That’s why we still need to pass the bipartisan SAFER Banking Act, which during his campaign, President Trump urged Congress to send to his desk.” Ahead of the rescheduling announcement, the senator separately told Marijuana Moment that cannabis banking legislation was “on the back burner,” with Democrats focused on other priorities such as preserving health care subsidies under the Affordable Care Act. “I will continue to push for fully descheduled cannabis—which is essential to addressing the harms perpetuated by the War on Drugs and the criminalization of cannabis on communities of color—and work with both Republicans and Democrats to advance common-sense cannabis reforms for banking services and medical treatment,” Merkley said. Sen. Ron Wyden (D-OR) Wyden said rescheduling is “just a half step that doesn’t include legalization, doesn’t put the nascent industry on stronger footing, and doesn’t do anything for the many Black and Latino Americans who are behind bars for the kind of cannabis use that millions of Americans engage in freely every day.” “I’ll continue pushing to pass my Cannabis Administration and Opportunity Act into law, which would legalize cannabis at the federal level and right the wrongs of the failed War on Drugs,” he said. Rep. Lucy McBath (D-GA) “Today, President Trump signed an executive order to reschedule marijuana, enabling researchers to study its medical benefits more effectively,” McBath said. “This order should serve as a critical first step toward meaningful criminal justice reform for marijuana-related offenses, as envisioned in the Clean Slate Act, which I lead.” “While the order will benefit the legal cannabis industry and medical research, reform cannot stop here. This order does not change the criminal penalties or considerations for marijuana-related offenses. Tens of thousands of individuals remain incarcerated for these offenses, and we cannot, in good faith, advance an industry while denying impacted individuals a clear path home to their families, an opportunity to return to their lives, and a chance to contribute in their communities. I stand ready to put people over profits and advance comprehensive criminal justice reform.” Photo courtesy of Mike Latimer. The post Marijuana Rescheduling Should Be Followed By Banking Access, Sentencing Reform And Legalization, Bipartisan Lawmakers Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Wow, excellent post. I'd like to draft like this too - taking time and real hard work to make a great article. This post has encouraged me to write some posts that I am going to write soon. nekatwin

I really liked how relaxed and easy the experience felt. After choosing Escorts Service in Karol Bagh, everything moved smoothly without confusion. The companion was respectful, friendly, and made me feel comfortable. She understood how to keep the mood calm and pleasant. The agency handled everything properly and kept full privacy. It’s a good option for anyone looking for a peaceful break and friendly company. I felt satisfied and comfortable throughout the time.

Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks crm for plumbers Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks evostoto alternatif Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks evostoto login Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks jasa review bintang 5 aplikasi android Great article Lot's of information to Read...Great Man Keep Posting and update to People..Thanks teknologi pangan